Dow futures edge lower as Wall Street closes out 2025
Proactiveinvestors NA· 2025-12-31 21:26
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - B&G Foods (NYSE:BGS), Corcept Therapeutics (NASDAQ:CORT)
Benzinga· 2025-12-31 21:26
U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.01% on Wednesday.Shares of Cybin Inc (NYSE:CYBN) fell sharply in pre-market trading.Cybin launched a $100 million at-the-market equity program with Cantor Fitzgerald.Cybin shares tumbled 6.6% to $8.00 in pre-market trading.Here are some other stocks moving lower in pre-market trading.Jefferson Capital Inc (NASDAQ:JCAP) shares dipped 7.2% to $21.08 in pre-market trading.SMX (Security Matters) PLC (NASDAQ:SMX) declined 6. ...
Excellent Results Boosted GE Aerospace (GE) in Q3
Yahoo Finance· 2025-12-31 21:25
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. The strategy underperformed the benchmark, the S&P 500® Total Return Index, this quarter, but still surpassed the index in dividend growth. The underperformance was due to a lack of significant exposure to the AI/TMT sector or the Value sector, which provides advantages stemming from the Federal Reserve's rate cut. The portfolio ret ...
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?
ZACKS· 2025-12-31 21:25
Key Takeaways BSX's EP business is expected to grow nearly 15% over the LRP, driven by share gains and ICE entry.BSX's WATCHMAN remains the top LAAC device, with growth tied to positive OPTION and CHAMPION trial results.Boston Scientific's ICTx, its most global cardiovascular unit, targets 10% growth and aims to beat markets.Boston Scientific’s (BSX) Cardiovascular segment operates in a $50 billion market, projected to grow nearly 9% over the 2026-2028 long-range plan (LRP). Management expects the business ...
4 Energy Stocks to Buy With $2,500 and Hold Forever
Yahoo Finance· 2025-12-31 21:25
As of late 2025, GE Vernova's backlog is $135 billion, and it expects it could grow to $200 billion by 2028 . In its gas turbine segment alone, the pipeline of signed orders and slot reservations is approaching 70 GW, showing robust demand for future services.GE Vernova is a strong pure play on rising U.S. energy demand. As data center buildout continues, high demand for its efficient gas turbines is surging. That's because one of the primary obstacles for hyperscalers is energy and the time it takes to exp ...
Novo Nordisk A/S: China's Supreme People's Court delivers a positive ruling on the semaglutide compound patent
Globenewswire· 2025-12-31 21:24
Bagsværd, Denmark, 31 December 2025 – Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent. Novo Nordisk is pleased that the Court has upheld the Beijing IP Court ruling recognising the validity of the semaglutide compound patent. “This outcome is very positive for semaglutide and demonstrates firm government support for protecting medical innovation,” said Mike Doustdar, president and CEO of Novo Nordisk. ...
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
Globenewswire· 2025-12-31 21:24
Bagsværd, Denmark, 31 December 2025 – Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent. Novo Nordisk is pleased that the Court has upheld the Beijing IP Court ruling recognising the validity of the semaglutide compound patent. “This outcome is very positive for semaglutide and demonstrates firm government support for protecting medical innovation,” said Mike Doustdar, president and CEO of Novo Nordisk. ...
Here’s What Lifted Thermo Fisher Scientific (TMO) in Q3
Yahoo Finance· 2025-12-31 21:22
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. The strategy underperformed the benchmark, the S&P 500® Total Return Index, this quarter, but still surpassed the index in dividend growth. The underperformance was due to a lack of significant exposure to the AI/TMT sector or the Value sector, which provides advantages stemming from the Federal Reserve's rate cut. The portfolio ret ...
Vitesse Energy: Strong Hedging And Low Costs Make It A Buy Despite Oil Headwinds
Seeking Alpha· 2025-12-31 21:22
I've been researching companies in-depth for over a decade, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for readers. After writing my own blog for about 3 years, I decided to switch to a value investing-focused YouTube channel, where I researched hundreds of different companies so far. I would say my favorite type of company to cover are metals and mining stocks, but I am comfortabl ...
Bristol Gate US Equity Strategy Exited Its Stake in Marsh & McLennan (MMC)
Yahoo Finance· 2025-12-31 21:21
Bristol Gate Capital Partners, an investment management company, published its Q3 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. The strategy underperformed the benchmark, the S&P 500® Total Return Index, this quarter, but still surpassed the index in dividend growth. The underperformance was due to a lack of significant exposure to the AI/TMT sector or the Value sector, which provides advantages stemming from the Federal Reserve's rate cut. The portfolio ret ...